$1.62
0.021.25%
At Close: -
$1.62
00.00%
After Hours: 4:00 PM EDT
15 minutes delayed
Comments
Loading...
Regulus Therapeutics (RGLS) Forecast
NewsEarningsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestRegulus Therapeutics (NASDAQ:RGLS) Stock Quotes, Forecast and News Summary
Regulus Therapeutics Stock (NASDAQ: RGLS) stock price, news, charts, stock research, profile.
| Open | $1.62 |
| Close | $1.62 |
| Volume / Avg. | 296.70K / 777.55K |
| Day Range | $1.59 - $1.67 |
| 52 Wk Range | 1.08 - 3.79 |
| Market Cap | $106.05M |
| P/E Ratio | - |
| Dividend Yield | - |
| Exchange | NASDAQ |
| RSI | 50 |
| Short Interest | 6.46% |
| Days to Cover | 9.86 |
Financials
Quarterly
Annual
| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
About Regulus Therapeutics Inc
Sector
Health Care
Industry
Biotechnology
Regulus Therapeutics Inc is a biotechnology company focused on the development of microRNA therapies...
Show More
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Regulus Therapeutics (RGLS) stock?
You can purchase shares of Regulus Therapeutics (NASDAQ:RGLS) through any online brokerage.
Who are Regulus Therapeutics (RGLS) competitors?
Other companies in Regulus Therapeutics’s space includes: Renovaro (NASDAQ:RENB), Anixa Biosciences (NASDAQ:ANIX), CytomX Therapeutics (NASDAQ:CTMX), bluebird bio (NASDAQ:BLUE) and Eledon Pharma (NASDAQ:ELDN).
What is the forecast, or price target, for Regulus Therapeutics (RGLS) stock?
Regulus Therapeutics has a consensus price target of $10.33.
What is the current price for Regulus Therapeutics (RGLS)?
The stock price for Regulus Therapeutics (NASDAQ: RGLS) is $1.62 last updated September 18, 2024 at 4:00 PM EDT.
Does Regulus Therapeutics (RGLS) pay a dividend?
There are no upcoming dividends for Regulus Therapeutics.
When is Regulus Therapeutics (NASDAQ:RGLS) reporting earnings?
Regulus Therapeutics’s Q3 earnings are confirmed for Thursday, November 7, 2024.
Is Regulus Therapeutics (RGLS) going to split?
There is no upcoming split for Regulus Therapeutics.
What sector and industry does Regulus Therapeutics (RGLS) operate in?
Regulus Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.